These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 39355255)

  • 21. Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy.
    Zhang Y; Zhang C; He J; Lai G; Li W; Zeng H; Zhong X; Xie B
    Inflamm Res; 2024 Aug; 73(8):1393-1409. PubMed ID: 38896289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses.
    Hu X; Hu Z; Zhang H; Zhang N; Feng H; Jia X; Zhang C; Cheng Q
    Cancer Lett; 2024 Jan; 581():216466. PubMed ID: 37944578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
    Wu X; Chen S; Ji Q; Chen H; Chen X
    Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancing lung adenocarcinoma prognosis and immunotherapy prediction with a multi-omics consensus machine learning approach.
    Lin H; Zhang X; Feng Y; Gong Z; Li J; Wang W; Fan J
    J Cell Mol Med; 2024 Jul; 28(13):e18520. PubMed ID: 38958523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leveraging single-cell sequencing analysis and bulk-RNA sequencing analysis to forecast necroptosis in cutaneous melanoma prognosis.
    Xie J; Zhang P; Tang Q; Ma C; Li M; Qi M
    Exp Dermatol; 2024 Jul; 33(7):e15148. PubMed ID: 39051739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma.
    Liu D; Yang X; Wu X
    Front Immunol; 2021; 12():663495. PubMed ID: 34025664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
    Li X; Cai Y
    Aging (Albany NY); 2020 Aug; 12(16):16457-16475. PubMed ID: 32858528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response.
    Wu Y; He H; Zheng K; Qin Z; Cai N; Zuo S; Zhu X
    Pigment Cell Melanoma Res; 2024 Jul; 37(4):496-509. PubMed ID: 38624045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
    Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
    Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
    Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi‑omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma.
    Xu S; Chen X; Ying H; Chen J; Ye M; Lin Z; Zhang X; Shen T; Li Z; Zheng Y; Zhang D; Ke Y; Chen Z; Lu Z
    BMC Cancer; 2024 Sep; 24(1):1138. PubMed ID: 39267056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel disulfidptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients.
    Cheng S; Wang X; Yang S; Liang J; Song C; Zhu Q; Chen W; Ren Z; Zhu F
    Skin Res Technol; 2024 Jul; 30(7):e13814. PubMed ID: 38924611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
    Yingjuan W; Li Z; Wei C; Xiaoyuan W
    Medicine (Baltimore); 2021 May; 100(21):e26017. PubMed ID: 34032721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of Bioinformatics and Machine Learning to Identify CD8+ T Cell-Related Prognostic Signature to Predict Clinical Outcomes and Treatment Response in Breast Cancer Patients.
    Wu B; Li L; Li L; Chen Y; Guan Y; Zhao J
    Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
    Liang L; Mai S; Mai G; Chen Y; Liu L
    Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene set.
    Zhang S; Ta N; Zhang S; Li S; Zhu X; Kong L; Gong X; Guo M; Liu Y
    Cancer Lett; 2024 Jul; 594():216981. PubMed ID: 38795761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing a machine learning-based prognosis and immunotherapeutic response signature in colorectal cancer: insights from ferroptosis, fatty acid dynamics, and the tumor microenvironment.
    Zhu J; Zhang J; Lou Y; Zheng Y; Zheng X; Cen W; Ye L; Zhang Q
    Front Immunol; 2024; 15():1416443. PubMed ID: 39076986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma.
    Shen K; Wang Q; Wang L; Yang Y; Ren M; Li Y; Gao Z; Zheng S; Ding Y; Ji J; Wei C; Zhang T; Zhu Y; Feng J; Qin F; Yang Y; Wei C; Gu J
    Eur J Med Res; 2023 Sep; 28(1):352. PubMed ID: 37716991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.